Cancer BiologyEMBO Molecular MedicinePeer-reviewed
FGF19 and its analog Aldafermin cooperate with MYC to induce aggressive hepatocarcinogenesis
José Ursic Bedoya, Guillaume Desandré, Carine Chavey…·Damien Grégoire
This study shows that FGF19 and its analog Aldafermin cooperate with MYC to drive aggressive hepatocarcinogenesis in mice, raising concerns about the safety of Aldafermin in patients with compromised livers.
15 citations